# Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer

> **NCT01875198** · NA · TERMINATED · sponsor: **Yonsei University** · enrollment: 1 (actual)

## Conditions studied

- Left-sided Pancreatic Cancer
- Ductal Adenocarcinoma

## Interventions

- **PROCEDURE:** Radical Antegrade Modular Pancreatectomy with Splenectomy
- **PROCEDURE:** Radical Antegrade Modular Pancreatectomy without splenectomy

## Key facts

- **NCT ID:** NCT01875198
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** because of difficulties of enrolling appropriate participants
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875198, "Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01875198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*